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Data from the World Health Organization (WHO) suggest
that the number of people that suffer from cardiovascular
diseases (CVDs) will increase from 17.3, in 2008, to 23.3
million by 2030. In vascular surgery, surgical bypass is
fundamental in the treatment of some diseases. Vascular
grafts replace, bypass or maintain function of damaged,
occluded or diseased blood vessels. The chosen conduit, and
its success, depends on several factors such as availability,
size, ease of handling and technical facility, thromboge-
nicity, resistance to infection and dilation, durability, long-
term patency, and price.[1,2]
Themost common, andgenerally considered ideal grafts,
are autografts, i.e., vessels collected from the patient. There
are generally twomajor downsides to the use of autografts.
The first is the need for additional surgical interventions,
before the actual bypass surgeries, in order to collect the
autologous vessel thatwill thenbeused as the bypass graft.DOI: 10.1002/mabi.201500251 139
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140Alongwith this, the actual availability of these vesselsmay
be limited, due toprior interventions. Secondly, these grafts
are subject to the natural progression of the patient’s
disease which can lead to deterioration, over time, of the
biological grafts[3] and so synthetic graftshavebeenusedas
cardiovascular grafts.
Polyethylene terephthalate (PETorDacron)andexpanded
polytetrafluoroethylene (ePTFE) graftsare thegold standard,
at the moment, for synthetic grafts in large and medium
diameter (>6mm) vessels. However, these synthetic alter-
natives are not yet the ideal solution. While demonstrating
acceptable results in larger diameter grafts, as internal
diameter decreases so does its long-term patency.[4,5] These
grafts ultimately fail under 6mm in diameter, due to neo-
intimal hyperplasia and/or thrombosis.[6,7]
A large amount of work has, therefore, been aimed at
finding alternative solutions to these materials through
either natural or synthetic polymer materials.[2,8–10] The
field is ever growing and the lack of a clear optimal polymer
has led, and continues to lead, to many potential options,
eitherby furtherdeveloping alreadyexistinggrafts (PETand
ePTFE) or creating new non-degradable grafts of polyur-
ethane,polyvinylalcohol,orbacterial cellulose (BC).Another
option is researching and developing temporary grafts that
ultimately allow for a tissue engineered solution, either by
prior cell-seeding or allowing for native cell migration,
attachment, and ingrowth. Ultimately, these tissue engi-
neered grafts would end up producing a new vessel out of
native tissue from a scaffold made of, e.g., collagen, fibrin,
elastin, silk, and polycaprolactone.[11–14]
One promising candidate is BC. This polymer is a highly
pure linear polysaccharide, consisting of b (1!4)–linked
d-glucose monomers. It is secreted by bacteria of the
Gluconacetobacter genus. Once secreted, it forms a fibrous
network hydrogel that has been extensively studied for
biomedical applications due to its morphology, high purity,
water-holding capacity, tensile strength, malleability, and
biocompatibility[15–17] and has been proposed for applica-
tions such as wound dressings,[18] artificial skin[19] or blood
vessels,[20–22] andasa scaffold for tissueengineering.[17,23,24]
The hemocompatibility of BC has been comprehensively
studied in our group, with rather promising results.[19]
Many methods have been proposed and patented[25–32]
for the production of BC tubular grafts. Generally, the
methods employed take advantage of the way the BC
hydrogel is produced at air-medium interfaces.[16,33] How-
ever, these production methods require dedicated bioreac-
tors specifically designed for graft production. An oxygen
permeable support scaffold provides a three-dimensional
surface upon which BC is produced. The thickness and
density of the BC structures produced by this method is
limited, due to the oxygen rich environment produced
being limited to the immediate vicinity of that oxygen
permeable silicone tube. Additionally, oxygen mustMacromol. Biosci. 20
 2015 WILEY-VCH Verlag Gmbpermeate consistently and homogenously throughout
the silicone otherwise the thickness of the produced BC
will not be homogenous. Also, some cases develop
interconnected sheets or layers of BC in the wall of the
graft. These sheets can potentially delaminate under
arterial pressure resulting in pockets of pooled blood and
pressure build-upwhich results in the graft ballooning and
bursting. This heterogeneity in the BC structure translates
to varying mechanical properties along and across a single
BC tube. Also, the bioreactors required for the production of
the BC tubular structures are complex and difficult to
operate if large scale is envisaged. Hence, a viablemodel for
large scale BC graft production is yet to be developed.
BC is produced commercially in membranes or sheets
with varying thicknesses and scale. We believe these
methods for graft production, as presented to date, have an
inherent inability to assure an economically viable and
reproducible approach to thegraftproduction. In thispaper,
we present a novel approach to small caliber BC graft
(<6mm) production that is both easily reproducible and
provides a graftwith adequatemechanical and biocompat-
ible properties and, through in vivo experimentation, has
already demonstrated promising patency.2. Experimental Section
2.1. Graft Fabrication
2.1.1. Bacterial Cellulose Production
Bacterial cellulose was produced by Gluconacetobacter xylinus
(ATCC 53582) in a modified Hestrin–Schramm medium, supple-
mented with 2% Corn Steep Liquor (Sigma–Aldrich, Germany) and
0.6% ethanol, at pH 5.0. The resulting BC membranes were then
washed in 4% (w/v) NaOH. The membranes were then thoroughly
washed with distilled water until pH was neutral.
2.1.2. Endotoxin Removal Assay
Endotoxin removal was performed as follows: quadruplicate BC
samples (1.52.5 4 cm3) were placed in 200ml of distilledwater
(control) and5%SDS (w/v). Thewater anddetergent solutionswere
changed after every 24h over the course of 3 d. Duplicate BC
samples were taken daily after each washing step, washed
abundantlywith distilled water, frozen at80 8C and freeze-dried,
prior to endotoxin quantification. The samples were subsequently
cut intosamplesof thesameweight20 4mgandrehydratedwith
500ml of apyrogenicwater. The concentration of endotoxin in each
sample was determined using the Pierce LAL Chromogenic
Endotoxin Quantitation Kit (Thermo Scientific, Rockford, IL USA).2.2. Graft Manufacturing
BC grafts were prepared by cutting large BC sheets (1.5 25
30 cm3) into 1.52.57 cm3 blocks. These were then washed in16, 16, 139–150
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www.mbs-journal.de5%SDS (w/v) over4d,with thedetergent solutionbeingexchanged
every 24h, then washed abundantly with distilled water. The
blocks were then perforated along the center of the sample with a
sharp 4mm (outer diameter) metallic needle and then dried by
mass transfer of water from the hydrogel to blotting paper until a
final wall thickness of roughly 2mm was achieved. The resulting
tubular structures were then freeze-dried and stored at room
temperature until needed (see Figure 1). All grafts tested had a
luminal caliber of 4mmand independently of the final lengthused
in thevarious assayswere initially 7 cm long. TheBCgrafts used for
in vivo experimentation were rehydrated in sterile 0.9% (w/v)
saline solution and autoclaved at 121 8C for 20min 72h before
surgery.2.3. Surface Profilometry
Freeze-driedBCgraftswere split open longitudinallyandfixedwith
double-sided tape to glass slides. Porcine femoral artery, commer-
cial ePTFE, and PET graftswere also split longitudinally and affixed
the same way (PET grafts were stretched as much as possible in
order to remove the kinking inherent to the graft). BC grafts, ePTFE,
and PET were all tested dry while the porcine femoral artery was
briefly paper-dried, to remove excess water, before analysis. No
tensile strain was applied to the samples, other than that required
to un-kink the PET grafts.
Thesamplesurfaceprofileswere thenmeasuredfivetimesalong
the same surface (each measurement roughly 1mm apart) with a
KLC TENCOR D-100 profilometer along 20mm (for porcine femoral
artery, ePTFE, and PET) and 30mm for BC at a set speed of
0.2mm  s1 and a resolution of 2000 points per mm. The results
were then plotted on a three-dimensional graph so to convey anFigure 1. Photograph of the three stage process of graft production: (A
freeze-dried graft with 3mm of luminal channel diameter. (E) Schem
left to right: the BC perforated with a sharp metallic needle, dried by
Macromol. Biosci. 20
 2015 WILEY-VCH Verlag Gmwww.MaterialsViews.comidea of the three-dimensional surface of the each sample. Rough-
ness was calculated as the amplitude between maximum peak
height and minimum valley depth.2.4. Cryo-SEM Imaging
Cross-sections of the BC graftswere imagedvia Cryo-SEMon a JEOL
JSM 6301F/Oxford INCA Energy 350/Gatan Alto 2500. The graft
sampleswere prepared as described above and then cut into 1mm
widesectionsandplacedupright inametallic support. Thesamples
were then rapidly cooled by plunging them into sub-cooled
nitrogen (slushnitrogen) and transferred under vacuumto the cold
stageof thepreparationchamber.Thesampleswere thenfractured,
sublimated for 180 s at90 8C, and sputter coatedwith Au/Pd. The
sampleswerefinally transferred into theSEMchamberand imaged
at150 8C. Pore sizewasestimated fromthemicrographsusing the
freeware ImageJ (National Institutes of Health, Maryland, USA).
Thesemeasurementswereperformedusingthemeandiameterofa
circle a total of 30 times over 4 micrographs.2.5. Mechanical Tests
2.5.1. Tensile Strength Determination
BC grafts, along with unprocessed BC grafts (unBC grafts—not
freeze-dried ones), ePTFE, and porcine femoral artery (PFA) were
testedfor their longitudinal tensilestrength inquintuplicate (n¼5)
onaShimadzuAG-X50kNata tractionspeedof5mm min1anda
load cell of 1 kN. Each sample tested was split open longitudinally
and the materials thickness (2.430.24mm, 2.360.19mm,) perforation, (B) shaping, (C) freeze-dried graft. (D) Top end view of a
atic representation of the BC vascular graft formation process. From
capillary action and shaped into a cylinder and finally freeze-dried.
16, 16, 139–150
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1420.690.01mm, 0.550.01mm for BC, unBG, ePTFE, and PFA,
respectively) and width (14.670.57mm, 17.90 0.55mm,
12.210.69mm, 15.951.39mm for BC, unBG, ePTFE, and PFA)
was measured with digital calipers and accounted for in the
calculations of the strength parameters. The distance between
clamps was set to 25mm for all samples tested.
BC and porcine femoral artery were tested wet and so special
care was taken in order to prevent sample slipping from the
hydraulic grips by using both fine grain sandpaper and con-
structionpaper. The sameconditions toprevent slippingwereused
on the ePTFE samples. The Young’s moduli were calculated
automatically, using the equipment software, by linear fit over
the linear deformation of each stress–strain curve and then
averaged to obtain the material’s Young’s modulus.
2.5.2. Suture Retention Assay
Wet BC graftswith 6 cm length (4mm internal diameter and 7mm
external diameter) were fixed the top clamp of a Z2.5 Zwick/Roell
(Zwick GmbH & Co. KG; Ulm; Germany). A 4-0 Prolene suture
(0.15mmdiameter; Ethicon)wasplacedapproximately7mmfrom
the edge of the prosthesis and 2–3 cm from the top clamp
(measured with a digital micrometer) and looped around the
bottom clamp before clamping. The assay was then carried out in
quintuplicate, on both freeze-dried and non-freeze-dried bacterial
cellulose prosthetics, at a set speed of 10mm min1 and a 1N
pre-load.2.5.3. Compliance Characterization
Compliance characterization of BC grafts (n¼5) was performed
using the system and method described previously by Diaman-
touros and colleagues.[34] Briefly, the grafts were fixed into a
chamber and initially exposed to a steady flow of purifiedwater. A
pulse (1Hz)was addedbya linearmagnetic actuator. Thepressures
were stabilized at 80–120mmHg. Variations in the outer diameter
were measured by an optical micrometer sensor (LS-7030(M);
Keyence Deutschland GmbH, Neu-Isenburg, Germany) placed
perpendicularly to the graft. Pressures were recorded by pressure
transducers (CODAN pvd Critical Care GmbH; Forstinning,
Germany). The measurements were realized for 30 s once the
pressures were stable. Variations in the outer diameter and
pressures were recorded by a LabVIEW application (National
Instruments; Texas, USA). The circumferential compliance was
then calculated with the following equation:C ¼
DSystDDiastð Þ.
DDiast
PSyst  PDiast  100where C is compliance (% mmHg1), D is diameter (mm), and P is
pressure (mmHg). ‘‘Syst’’ and ‘‘Diast’’ stand for the systolic and
diastolic phase, respectively.
Additionally to the method presented by Kazmierczak and
Kazimierczak,[32] ultrasound imaging was used (Vivid I, GE
Healthcare; Freiburg, Germany) to monitor the changes of the
internal diameter in response to pressure variations. Ultrasound
videos were recorded from which still images were extracted and
analyzed with ImageJ to determine the diameter of the lumen atMacromol. Biosci. 20
 2015 WILEY-VCH Verlag Gmbthree different positions along the longitudinal direction per
image. Care was taken that the measurements from each video
were performed at the same coordinates in each individual frame
so as to account, as much as possible, for human error.2.6. In Vivo Experimentation and Histological
Analysis
2.6.1. Surgical Procedure
Three female domestic pigs (Sus scrofa domesticus) with weight
ranging from 30–40 kgwere restrained from food (24 h) andwater
(6 h) before surgical procedure. All experiments were conducted
according to the European Union Directive no.86/609/CEE for
the use of animals in research and approved by the board for the
ethical treatment of animals of the Faculty of Medicine of the
University of Porto (ORBEA, FMUP, Oporto, Portugal). All
procedures were performed under general anesthesia, with
endotracheal intubation and spontaneous ventilation. A pre-
anesthesia intramuscular injection of 32mg ml1 azaperone
(Stressnil, EsteveVeterinaria) at a dose of 4mg  kg1 reconstituted
with 1mg ml1 midazolam (Dormicum, Roche) at a dose of
0.15–0.2ml  kg1 was administered. Venous access was obtained
through an intra-venous (IV) line placed in the marginal ear vein.
Anesthesia was induced with 3mg  kg1 fentanyl (Fentanest,
Janssen-Cilag), and sodium thiopental (12.5mg  kg1 IV initially
and then to effect Tiopental 0.5 B Braun, B. Braun). After
orotracheal intubation, the 7- to 7.5-mm tube was connected to
the anesthetic equipment (Ohmeda, Boc Health Care), and
anesthesia was maintained with a mixture of isoflurane
(1.5–2.5%; Isoflo, Esteve Veterinaria) in 100% oxygen and fentanyl
at constant-rate infusion of 30–50mg  kg1 h1. Afterward an
epidural analgesia protocol was implemented with application of
1mg  kg1 morphine (Morfina 1% Braun, B. Braunl). To address
infection prophylaxis, all animals received intramuscular injec-
tion of 1 g ceftriaxone (Rocephin, Roche) before surgery. End-tidal
CO2, oxygen saturation, electrocardiography, and temperature
weremonitored continuously (Cygnus 1000CVetMonitor, Servive
Portugal). Pigs were placed in supine position and shaved, and
electrocardiographic electrodes were attached to the chest for
continuous evaluation of cardiac electrical function. Normal
saline (2–4mL  kg1 hourly) was infused through the venous
cannula in the auricular vein during surgery, to maintain
adequate preload stability.
Open surgery was then performed with isolation of the
common femoral artery, the profunda femoris artery and the
superficial artery. All BC grafts used in this study were previously
SDS washed, in order to remove endotoxin, as described above.
The BC grafts, with 3–4 cm in length, were anastomosed in the
left hind limb in a homolateral-femoral artery bypass. Papaverine
was administered topically to the artery to avoid arterial spasm.
The animals were heparinized systemically with an intravenous
bolus injection of 200U  kg1 of heparin (Heparina Sodica B.
Braun, B.Braun), 5min before clamping of the target arteries. BC
grafts were then anastomosed with continuous suture with 6/0
monofilament polypropylene sutures (Prolene, Ethicon). The
femoral artery from the right hind limb was exposed in a
sham-procedure.16, 16, 139–150
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quarters, only when arterial oxygen tension stabilized above
95%. Pigs were monitored until their body temperature
normalized (with digital thermometers) and they were able to
ambulate. They then were observed at least 2 or 3 times daily for
locomotor activity, respiratory changes, body temperature, and
food and water intake. Analgesia was maintained during the first
24 h after surgery by using meloxicam (0.5mg  kg1 IM;
Metacam, Boehringer Ingelheim). Acetylsalicylic acid (150mg/
animal per os daily; Acido Acetilsalicı´lico ratiopharm 100mg,
Ratiopharm) was given once daily until euthanasia, to prevent
platelet aggregation.
After thedesignated times, the animalswere sacrificedby IVKCl
injection after sedation with azaperone reconstituted with
midazolam administered IM prior to induction with sodium
thiopental (12.5mg  kg1 IV initially and then to effect) and the
grafts and sham-operated arteries were harvested and histolog-
ically evaluated for signs of chronic inflammation, infection,
foreignbody responses, clot formation, cell ingrowth, anddiameter
via electron microscopy.
2.6.2. Histology
Tissueswere preserved in formalin for aminimumof 4 d andwere
embedded in paraffin in an automated tissue processor (Microm
STP 120). Tissues were then transferred to embedding workstation
to obtain paraffin blocks. From these, sections (2mm)were cut on a
rotary microtome (Leica RM 2035) and stained with Hematoxylin
and Eosin (H&E) for light microscopic examination. Observations
and photographs were made using an Olympus BX51 microscope
equipped with an Olympus camera.
2.6.3. Immunohistochemistry
Immunostaining of endothelial cells was performed using the
primary antibody—Mouse Anti Pig CD31 (AbD Serotec; Oxford,
England). The slides were immersed in 10mM sodium citrate
(pH 6.0) buffer, and heated in a water bath (95–99 8C) for antigen
retrieval. Antigen visualization was done with the Novocastra
Novolink Polymer Detection System (Leica Microsystems GmbH,
Wetzlar, Germany) and involved the following steps: sectionswere
incubated with H2O2 (3%) for 10min to eliminate endogenous
peroxidase activity followed by a 5min incubation with a protein
blockingagent. Sectionswere subsequently incubatedovernight at
4 8Cwith the primary antibody diluted at 1:100with bovine serum
albumin (BSA) (5%), and on the following day, washed in TBS-
buffered saline solution before incubation for 30min with the
secondary anti-mouse antibody system, using diaminobenzidine
(DAB) as a chromogen, provided in the afore-mentioned kit.2.7. Statistical Data Analysis
All data and statistical analysis was performed using both
GraphPad Prism andOrigin Pro 9 software. Statistical significances
weredeterminedviaOne-wayandTwo-WayANOVA, in the case of
the endotoxin removal assay, tests after verifying the Normal
distribution (p< 0.05) of the data via the Kolmogorov–Smirnov
test.Macromol. Biosci. 20
 2015 WILEY-VCH Verlag Gmwww.MaterialsViews.com3. Results
3.1. Graft Fabrication
The novel methodology for the production of the BC graft
is documented and represented schematically in Figure 1.
The BC grafts were produced with needles that were
purposely built, regularly sharpened, and exchanged in
order to assure consistent perforation. Special care was
taken during perforation in order to assure a smooth
luminal surface. An unsharpened needle resulted in tears
during the perforation with the appearance of ‘‘flaps’’ that
could occlude or restrict flow through the graft. While all
grafts presented in this work were 4mm in diameter,
other diameters can be easily achieved by using different
needles.
The drying and shaping was performed with the needle
in place with special care to avoid changes to the luminal
diameter of the graft and an irregular topography of the
external surface. The grafts were found to dry quickly
during the freeze-drying process (a maximum of 2 d is
required for complete drying) and the least irregular grafts
were obtained the quicker this process was performed.3.2. Surface Profilometry
Our results show that the surface roughness of BC is in the
same range of that of porcine femoral artery (see Figure 2),
ranging roughly 300nminboth cases fromhighest peaks to
lowest valley, with no statistically significant difference
between them (p> 0.05). On theotherhand, bothePTFEand
PET showamuchgreater surface roughnesswith a distance
of approximately 600 and 1600nm between peaks and
valleys, respectively.3.3. Cryo-SEM Imaging
Several BC graft samples, and several different regions of
each graft, were observed via Cryo-SEM so as to maintain
the hydrated three-dimensional structure of the grafts; the
images presented here are representative of those obser-
vations (Figure 3). The fibril distribution inside of our grafts
showedmarkedly different structures throughout the graft
wall that are well distributed throughout. In lower
magnifications, dense sheets of BC fibers intersecting each
other are visible and appear in wave-like patterns, parallel
to the luminal surface of the graft (Figure 3A, B, and C).
Dense sheets are surrounded by low density open porous
regions (Figure3D)withpore sizes ranging from1to5mmin
diameter. Additionally, there seems to be a consistent and
dense single layer of BC fibers over the entire luminal
surface of the graft that is immediately followed by open
porous regions (Figure 3E).16, 16, 139–150
bH & Co. KGaA, Weinheim 143
Figure 2. Surface profiles of Porcine Femoral Artery (A), BC graft (B), ePTFE graft (C) and a PET graft (D). The plots were obtained from five
separate linear measurements (2000 points mm1) over 2 cm (3 cm for BC), spaced 1mm apart and plotted in a three-dimensional graph.
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1443.4. Endotoxin Removal Study
Endotoxin (Lipopolysaccharide; LPS) concentration on
water-washed and SDS-washed BC was determined with
the Pierce LAL Chromogenic Endotoxin Quantitation Kit.
Total LPS concentration on non-washed BC over the course
of the studywas 2.65 0.27 EU ml1 (EndotoxinUnits/ml)
and dropped to 0.43 0.15, 0.06 0.04, and 0.003 0.02
EU ml1 over the following 3 d (Figure 4). Total LPS
concentration was shown to be significantly different
between SDS-washed and water-washed BC (p< 0.05).
Results also show a significant difference between a single
and twice SDS-washed (p< 0.05) and no significant differ-
ence between the second and third washes.3.5. Mechanical Tests
3.5.1. Tensile Strength Determination
Mechanical testing demonstrated marked differences
between porcine femoral artery (PFA), ePTFE, BC and unBC
grafts)—see Table 1 and 2. The BC and unBC grafts show no
statistically significant difference between them (p> 0.05)
in regards to any of the parameters. However, the BC graft
did show higher values for maximum tensile strengthMacromol. Biosci. 20
 2015 WILEY-VCH Verlag Gmb(Max Force), maximum stress and strain. PFA, while
mechanically weak as compared to the other materials in
regards to strength, was by far the most elastic, deforming
133%before rupture. Also noteworthy, ePTFEwas shown to
be most rigid of the tested materials, with the highest
values in all the parameters. The BC grafts thus better
resembles the biological vessels than ePTFE, in the sense
that it presents higher elasticity, translated in a Young
modulus in the same order of magnitude as PFA’s.
3.5.2. Suture Retention Strength and Compliance
Characterization
Results showed that bothunBCandBCgrafts demonstrated
suture retention strength of 3.94 0.38 and 4.20 0.99N,
respectively, with no statistically significant difference
between them (p> 0.05). Also, we determined BC graft
compliance via laser detector and determined external
compliance to be 0.4 102% mmHg1.3.6. In Vivo Experimentation and Histological
Analysis
As a preliminary in vivo assay, 3 surgical procedures were
performed to date, with implantation of the BC graft in a16, 16, 139–150
H & Co. KGaA, Weinheim www.MaterialsViews.com
Figure 3. Cryo-SEM images of a portion of the cross-section of the graft wall. (A) and (B)
4000 magnification with noticeable dense regions layered between open-pore
structures; (C) 10000 magnification of the dense BC regions; (D) 10000
magnification of the open-pore structures and (E) 10000 magnification of the
edge of the luminal surface.
Figure 4. Endotoxin (LPS) concentration in EU/ml (Endotoxin
Units ml1) as determined after washing the BC in 5% SDS
and water (negative control).
A Novel Small-Caliber Bacterial Cellulose Vascular Prosthesis. . .
www.mbs-journal.de
Macromol. Biosci. 2016, 16, 139–150
 2015 WILEY-VCH Verlag GmbH & Co. KGaA, Weinhwww.MaterialsViews.comhomolateral-femoral artery bypass on
the left hind limb of female domestic
pigs (see Figure 5A). The right femoral
artery was also isolated in a sham-
operated procedure and served as a
control for the implanted graft. No
significant changes to the arterial wall
of the control vessel were detected.
All three procedures presented con-
firmed patency after 1m. The first of
these procedures was terminated one
month post-op with blood flow con-
firmed via Doppler ultrasound prior to
explantation, as also observed visually
during tissue collection and later in the
histological analysis. The final two pro-
cedures had a confirmed one month
patency via Doppler ultrasound. How-
ever, these two grafts were found to be
occluded two months post-op.
Histological analysis and immunohis-
tochemistry staining were performed on
the explanted grafts. All BC grafts were
found intact andwell integrated into the
surrounding tissue with no significant
fibrosis or macroscopic, external, evi-
denceof inflammation.Histological anal-
ysis showed a distinct, three-layered,
structure with cellular adhesion and
infiltration on both the luminal and
adventitial surfaces of the graft and an
unpopulatedand largerBCcentral region.
All non-patent grafts were found to have
an occlusive thrombus.
On the one-month patent graft, CD31
positive cells were detected on the
luminal surface and are believed to be
endothelial orprogenitorendothelial cells
thatmigrated from the adjoining femoralartery (Figure 5B and F). The presence of neo-vessel
formation was detected in the cell population on both the
adventitial and luminal surfaces (Figure 5C and E). It should
be noted that a significant unspecific background BC
staining occurred, somewhat compromising the contrast
of the images obtained. The specificity of the CD31 cells
stainingwasconfirmedinacross-sectionofthenativevessel
andalso it shouldbenoted that thestained cells observedon
the luminal surface of the grafts presented an endothelial-
like morphology. Figure 5D is representative of the cellular
infiltration and population found on the adventitial surface
of all the recovered grafts. The cell populations in the
adventitial regions were determined to be composed,
mostly, of fibroblasts, macrophages, and some giant cells
with a small population of lymphocytes also present.eim 145
Table 1. Mechanical test results for Porcine Femoral Artery (PFA), ePTFE, BC, and unBC grafts (n¼ 5).
Material Young’s modulus [N mm2] Max force [N] Max stress [N mm2] Max strain [%]
PFA 2.58 0.95 10.05 3.39 1.15 0.39 133.46 11.25
ePTFE 125.40 24.33 198.54 13.33 23.57 1.00 40.62 9.92
BC graft 10.56 1.53 95.92 5.62 2.75 0.38 41.08 8.65
unBC graft 10.70 2.23 91.47 16.33 2.10 0.26 34.50 4.27
Valuesmarkedwithanasterisk () arenot statistically different fromeachother in their respective columns (p>0.05).Dataarepresentedas
mean standard deviation.
Table 2. Suture Retention strength (N) of several autologous and
synthetic grafts for tissue engineered blood vessels (TEBV),
internal mammary artery (IMA), polytetrafluoroethylene
(ePTFE), fibrin and fibrin/polylactic acid (PLA), human




IMAa) 1.35 0.49 [49]
HSVa) 2.60 [50]
TEBVa) 1.49 0.49 [49]
Collagenb) 0.82–2.87 0.12–0.09 [51]
ePTFEc) 4.70 0.50 [52]
BCd) 4.20 0.99 –
unBCd) 3.94 0.38 –
Suture retention strength for the BC and unBC grafts are not
statistically different (p>0.05; n¼4). The methodology used for
suture retention measurements was as follows: a)2mm bite at
2mm min1, b)2.5mm bite at 2mm  s1, c)3mm bite at 20mm 
min1, d)7mm bite at 10mm min1; all performed with 5–0
sutures.
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1464. Discussion
The method for BC graft production is hinged on its
simplicity and a few steps, namely: perforation, simulta-
neous drying, and shaping and freeze-drying (Figure 1).
Perforation of the graft by a sharp needle allows a precise
control over the luminal diameter of the graft and directly
affects the structure of the luminal surface of the graft.
There is a consistent single dense layer of BC fibers over the
entire luminal surface of the graft (Figure 3E) that is
immediately followed by an open porous regions. As the
needle penetrates the cellulose block it pushes BC fibers out
of its way and to the sides, the end result is a dense inner
wall of BC fibers. This luminal surface plays an important
role in containing the blood in the lumen of the graft while
serving as a semi-permeable barrier to plasma andMacromol. Biosci. 20
 2015 WILEY-VCH Verlag Gmbpotentially adhered cells. Additionally, the surface created
by this layerofBCfibers isquite smoothand, in regards to its
profile, similar to that of a native artery (Figure 2). Non-
uniform blood flow and shear stress have been shown to
contribute to plaque formation.[35,36] Physiological levels of
shear maintain the homeostatic functioning of vessels and
so, ideally, grafts should aim for physiological levels of
shear.[37–41] In this regard, the topographyofbothePTFEand
PET isquite different from that of both BC and the artery
(Figure 2). The similarities between the surface roughness/
topography of the BC grafts and that of the arterial wall
should theoreticallymatch and allow for anun-interrupted
and consistent bloodflowover the transition fromartery to
graft maintaining physiological levels which, in the end, is
beneficial to graft performance. It should be noted that care
was taken to not apply any unnecessary tensile strain on
thesamples (other thanthatapplied toPETgrafts toun-kink
the graft), to avoid artifacts.
The partial capillary drying, shaping, and freeze-drying
steps are largely responsible for the final structural and
mechanical properties of the resulting grafts. The drying
and shaping allows the BC block to be shaped into a
cylindrical tube with 2mm in wall thickness. As a direct
result, the graft wall density is brought from 0.02 0.01 to
0.09 0.01 g  cm3, with the final freeze-drying step being
required to eliminate the remaining water. Theoretically,
this allows individual BC fibers to come into contact with
each other and form H-bonds,[42] while maintaining each
individual fiber’s spatial orientation.
The contact and bonds created between fibers induced
morphological changes in theBChydrogel (Figure 3). BChas
been extensively characterized as presenting an open
porous structure that is relatively homogenous throughout
the hydrogel.[16,42,43] Our grafts present a dual structure,
presenting dense sheets, formed by the collapse of fibers
ontoeachother in thedryingandwithbonds formedduring
freeze-drying, (Figure 3A and B) layered in between the
characteristic open porous morphology of BC (Figure 3D).
These two distinct regions/structures complement each
other structurally and functionally. The dense regions
observed at a micro/sub-micro scale provide a slight16, 16, 139–150
H & Co. KGaA, Weinheim www.MaterialsViews.com
Figure 5. Representative photographs of the microscopy images of in vivo tests.
(A) Femoral-femoral artery BC graft placement, black arrows indicate anastomosis’,
(B) luminal surface of the graft with cell adhesion on the surface of the graft along and
some cell infiltration, (C) external surface of BC graft showing formation of neo-vessels
(arrow), (D) close-up detail of external surface of the graft with giant cells (red arrow)
and macrophages (green arrow) among fibroblasts, (E) immunohistochemistry staining
of CD31 positive cells forming neo-vessels on the luminal surface of the graft, (F) CD31
positive cell clusters on the luminal surface of the grafts.
A Novel Small-Caliber Bacterial Cellulose Vascular Prosthesis. . .
www.mbs-journal.deincrease inmechanical support, while allowing the graft to
maintain the shape and structural integrity essential to a
functional vascular graft. Simultaneously, the open-porous
regions allowfor void spaceandpore interconnectivity that
in turn allows the graft to preserve its flexibility.
A final step in graft preparation was the removal of
bacterial lipopolysaccharide (LPS or endotoxin) from the
grafts by SDS wash. A significant amount of endotoxin
(2.65 0.27 EU ml1) remains on BC after alkaline wash, a
standard procedure in purifying BC, which has been shown
to induce a strong inflammatory response.[44] The inflam-
matory response triggers coagulationmechanics and could
subsequently cause thrombosis.A24hwashwasenoughto
significantly reduce the overall concentration of LPS in BC
by over 83% and a subsequent succession of two washes
leaving only residual levels of LPS.
In terms of tensile strength, unBC and the BC grafts show
no statistically significant difference between each other;
though there seems to be a slight increase in the tensileMacromol. Biosci. 2016, 16, 139–150
 2015 WILEY-VCH Verlag GmbH & Co. KGaA, Wwww.MaterialsViews.comstrength of the BC grafts likely due to the
higher number of bonds in the denser
regions (95.92 vs. 91.47N). Since, the total
number of BC fibers in a given cross-
section is essentially identical the higher
strength of the graft does not translate to
significantly higher values. BC fibers are
strong and inelastic[15] as opposed to
the native elastin which, has lower
tensile strength and is capable of great
deformation and shape memory. This is
evident when comparing the tensile
strength (95.92 vs. 10.05N) and elasticity,
or deformation, (41 vs. 133%) of the graft
compared to a porcine vessel.
Similar to what happens with the
tensile strength of the graft, suture
retention of the BC graft is influenced
by the inelasticity of the BC fibers when
compared to that of native vessels. The
large number of fibers, some organized
in the stronger dense regions, provides a
solid anchor point for the suture. This
translates to a suture retention strength
that is noticeably higher than that of
native vessels, which as mentioned,
tend to deform rather than resist the
tensile stress. This suture retention
strength is comparable to that of much
stronger and rigid materials like ePTFE
(see Table 2), though there are differ-
ences in the methodologies used that
must be accounted for when comparing
the results.
Another important consequence, of thedistribution and layered structure of the graft wall is the
compliance behavior of the graft. Intimal hyperplasia in
both autologous saphenous vein and synthetic artery
bypass grafts is a major reason for graft failure[45] and is
closely associated with a mismatch in mechanical
properties of the native vessel and the bypass graft.
Diastolic and systolic pressure changes cause vessel walls
to expand and contract. A mismatch in mechanical
properties of native vessels and grafts adds direct stress to
ingrown tissues. Specifically, this occurs at the point
where the mechanical properties of the vessel wall
changes. This can cause lesions to the cell layers which
can expose underlying smooth muscle cells resulting in
an abnormal migration and proliferation, along with
the deposition of extracellular matrix, in the intimal
layer (intimal hyperplasia). This leads to thickening of the
vessel wall and causing a reduction in the lumen of
the vessel, restricting blood flow which can eventually
cause occlusion.[46]einheim 147
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148Compliancewas determinedwith a veryprecisemethod,
using a laser detector and, results showed a value that
would place the BC grafts in region of a non-compliant
material (0.4 102% mmHg1) (see Table 3). This is an
unexpected result suggesting that there would be a
mismatch in mechanical properties between BC grafts
and native arteries, somewhat contradictory with the
experience one might have while manipulating the
material, which appears to be rather biomimetic owing
to theveryhighwater content, fairly easy to expel bygentle
pressure. Thus, our experience suggests that the malle-
ability and flexibility of the graft, along with the wall
structure observed in the SEM imaging, allows it to absorb
the pressure change. We believe the graft wall retains a
measure of compressibility and as such, a pulse would not
be translated to the external surface of the graft. The open
porous regions of the graft, as mentioned, provide void
spaces thatallowforfibermovement inside thegraftwall in
response to pressure changes.
The three implanted graftswere confirmed patent at one
month post-op via Doppler ultrasound. One experiment
was terminated at onemonth and the BC graft recovered in
order to perform histological and immunohistochemical
analysis. The other two procedures were terminated after
twomonths when Doppler ultrasound confirmed no blood
flow. These grafts were found occluded by thrombi. No
evident macroscopic signs of inflammation were visible at
the explantation. A large population of fibroblasts and
macrophages, alongwith giant cells anda small population
of lymphocytes could be observed in the thrombi. There
appeared to be some blood flow, due to the presence of redTable 3. Compliance values (SD) as found from the literature for
internal mammary artery (IMA), human saphenous vein (HSV),
human iliac artery (HIA), tissue engineered blood vessel (TEBV),
polyurethane (PU), polyethylene terephthalate (PET), expanded
polytetrafluoroethylene (ePTFE), bacterial cellulose/chitosan
blend (BC/Chi) and measurements for the compliance of the




IMA 11.5 3.9 [49]
HSV 3.7–12.8 1.3–1.9 [53]
HIA 8.0 5.9 [54]
TEBV 1.5-3.4 0.3 [49,50]
PU 8.1 0.4 [54]
PET 1.8 1.2 [54]
ePTFE 1.2–1.6 0.3 [45,54]
BC/Chi 5.9 2.7 [45]
BC graft 0.4 0.1 –
Macromol. Biosci. 20
 2015 WILEY-VCH Verlag Gmbblood cells and channels in the thrombi though flowwould
be severely restricted. No evident behavioral signs of
occlusion could be observed in the live animals due to
collateral circulation compensating for the restricted blood
flow in the femoral artery. We believe that the occlusions
we observed after two months of implantation are
associated with handling of the animals to perform the
ultrasound imaging after one month. The animals had to
be handled in order to administer the sedative and due to
their size and strength this process was somewhat rough
and could have caused lesions to the anastomosis site.
Furtherwork is being conducted in order to ascertain if this
is indeed true.
The results, in regards to in vivo experimentation, are
still in their early stages yet, as compared to the findings of
both Malm et al.[47] and Wipperman et al.[48] The luminal
surface in this graft was largely populated by a cell
population containing endothelial, or endothelial-like cells,
a fibroblast population, alongwith somemacrophages and
giant cells, covered and infiltrated the adventitial surface.
The occurrence of neo-vessel formationwas found both, on
the luminal and adventitial surfaces of the grafts. Cell
infiltration and adhesion is largely limited to the surface
and immediate vicinity of the graft, the interior of the BC
graft wall remaining largely unpopulated. Both Malm
et al.[47] and Wipperman et al.[48] reported similar findings
thoughnoneo-vessel formationwas reported in their cases.
While coverage of the grafts adventitial surface was
complete, the exact extension of surface coverage on the
luminal surface couldnotbepreciselydetermined.Also, the
origin of the cells on the adventitial and luminal surfaces is
undetermined. However, we believe these to be, in large
part, cells that would have migrated from the anastomotic
sites, at least in regards to the luminal surface, rather than
circulating cells that adhered to the BC graft surface
similarly to what was proposed by Malm et al.[47]5. Conclusion
Several methods have been proposed and patented for BC
graft production, all requiring dedicated bioreactors and
production protocols. Our novel approach has allowed us to
produce a dense, malleable, and mechanically strong
tubular BC prosthesis. In vitro, the BC grafts herein
presented seem to constitute a suitable alternative as
synthetic vascular grafts, though in vivo experimentation
has yet to confirm the viability of the BC grafts we here
present.
Thiswork is still ongoingmostly in order to expandupon
the sample size of the in vivo tests, as well as, prolonging
those same tests into longer implantation times in order to
gain a more significant perspective of the feasibility of a
BC grafts as a long-term, off-the-shelf, and cost-effective16, 16, 139–150
H & Co. KGaA, Weinheim www.MaterialsViews.com
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www.mbs-journal.desynthetic graft. Continued work will demonstrate any
further limitations of the grafts, as is, and allow us to
address possibilities such as nanocompositing the graft
with other polymers, such as fibrin, or surface modifica-
tions, like the incorporation of heparin, in order to extend
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